Xeris制药(XERS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

XERS Xeris制药

盘后交易 12-29 17:40:29 EST

7.43

+0.06

+0.81%

盘后7.43

+0.000.00%

17:24 EST

最高7.47	最低7.20	成交量138.58万
今开7.30	昨收7.37	日振幅3.60%
总市值12.33亿	流通市值11.81亿	总股本1.66亿
成交额1,024万	换手率0.87%	流通股本1.59亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"XERS","market":"US","secType":"STK","nameCN":"Xeris制药","latestPrice":7.43,"timestamp":1767042000000,"preClose":7.37,"halted":0,"volume":1385794,"hourTrading":{"tag":"盘后","latestPrice":7.43,"preClose":7.43,"latestTime":"17:24 EST","volume":44842,"amount":333176.06,"timestamp":1767047080269},"delay":0,"floatShares":159000000,"shares":165924289,"eps":-0.10439,"marketStatus":"盘后交易","change":0.06,"latestTime":"12-29 17:40:29 EST","open":7.3,"high":7.465,"low":7.2,"amount":10242602.0382802,"amplitude":0.035957,"askPrice":8.32,"askSize":100,"bidPrice":7.21,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-0.10439,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1767056400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1529553600000,"exchange":"NASDAQ","adjPreClose":7.37,"preHourTrading":{"tag":"盘前","latestPrice":7.3,"preClose":7.37,"latestTime":"09:29 EST","volume":134,"amount":969.099792,"timestamp":1767018570091},"postHourTrading":{"tag":"盘后","latestPrice":7.43,"preClose":7.43,"latestTime":"17:24 EST","volume":44842,"amount":333176.06,"timestamp":1767047080269},"volumeRatio":0.658598,"impliedVol":0.6905,"impliedVolPercentile":0.252},"requestUrl":"/m/hq/s/XERS","defaultTab":"news","newsList":[{"id":"1139128234","title":"Xeris制药第三季度净利润为62.1万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1139128234","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139128234?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:56","pubTimestamp":1763571385,"startTime":"0","endTime":"0","summary":"11月6日 - Xeris制药第三季度每股收益为0美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XERS","BK4007"],"gpt_icon":0},{"id":"2582316025","title":"Xeris制药盘中异动 急速下挫5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582316025","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582316025?lang=zh_cn&edition=full","pubTime":"2025-11-12 01:10","pubTimestamp":1762881039,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日01时10分，Xeris制药股票出现波动，股价大幅下跌5.05%。截至发稿，该股报7.33美元/股，成交量94.2084万股，换手率0.57%，振幅5.27%。Xeris制药股票所在的生物技术行业中，整体涨幅为1.29%。Xeris制药公司简介：Xeris Biopharma Holdings Inc 是一家美国生物制药公司，专注于开发和商业化慢性内分泌和神经疾病患者的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112011039a49a52c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112011039a49a52c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XERS","BK4007"],"gpt_icon":0},{"id":"2581008391","title":"Xeris制药盘中异动 早盘股价大跌14.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581008391","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581008391?lang=zh_cn&edition=full","pubTime":"2025-11-06 22:33","pubTimestamp":1762439592,"startTime":"0","endTime":"0","summary":"北京时间2025年11月06日22时33分，Xeris制药股票出现波动，股价快速下挫14.49%。截至发稿，该股报8.44美元/股，成交量80.0353万股，换手率0.50%，振幅6.56%。机构评级方面，在所有6家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。Xeris制药股票所在的生物技术行业中，整体涨幅为0.02%。Xeris制药公司简介：Xeris Biopharma Holdings Inc 是一家美国生物制药公司，专注于开发和商业化慢性内分泌和神经疾病患者的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106223312a48dae2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106223312a48dae2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XERS","BK4007"],"gpt_icon":0},{"id":"1158245930","title":"Xeris Biopharma 2025财年Q3业绩会总结及问答精华：Recorlev推动增长，XP 8121临床试验准备中","url":"https://stock-news.laohu8.com/highlight/detail?id=1158245930","media":"业绩会速递","labels":["earningsCall"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158245930?lang=zh_cn&edition=full","pubTime":"2025-11-06 22:21","pubTimestamp":1762438891,"startTime":"0","endTime":"0","summary":"管理层强调，增长主要由Recorlev的强劲表现推动，其收入同比增长109%，患者数量增长108%。未来计划包括扩大销售团队规模以支持Recorlev的市场渗透，并为XP 8121的2026年三期临床试验做好准备。Recorlev被认为是市场中最优产品，目标是成为“十亿美元级产品”。问题5：XP 8121临床试验的时间表和研发投资趋势如何？Recorlev继续成为增长引擎，XP 8121的研发进展也为未来增长奠定了基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"earningsCall","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XERS"],"gpt_icon":0},{"id":"2561483903","title":"Xeris制药8月19日成交额为1524.95万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2561483903","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561483903?lang=zh_cn&edition=full","pubTime":"2025-08-20 17:21","pubTimestamp":1755681674,"startTime":"0","endTime":"0","summary":"美东时间2025年8月19日，Xeris制药成交额为1524.95万美元，成交额较昨日减少26.36%，当日成交量为204.36万股。Xeris制药于2025年8月19日涨0.0%，报7.36美元，该股过去5个交易日涨0.82%，年初至今涨117.11%，过去60日涨50.82%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-19|1524.95万|-26.36%|204.36万|#|2025-08-18|2070.70万|-21.92%|277.48万|#|2025-08-15|2651.99万|66.61%|351.91万|#|2025-08-14|1591.72万|-18.10%|219.37万|#|2025-08-13|1943.56万|-25.30%|266.66万|Xeris Biopharma Holdings Inc 是一家美国生物制药公司，专注于开发和商业化慢性内分泌和神经疾病患者的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250820172801a6f0e5d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250820172801a6f0e5d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XERS","BK4007"],"gpt_icon":0},{"id":"2558826666","title":"Xeris制药盘中异动 股价大涨5.48%报7.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558826666","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558826666?lang=zh_cn&edition=full","pubTime":"2025-08-11 21:34","pubTimestamp":1754919276,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日21时34分，Xeris制药股票出现波动，股价急速拉升5.48%。截至发稿，该股报7.22美元/股，成交量37.5379万股，换手率0.23%，振幅5.99%。Xeris制药股票所在的生物技术行业中，整体跌幅为0.19%。Xeris制药公司简介：Xeris Biopharma Holdings Inc 是一家美国生物制药公司，专注于开发和商业化慢性内分泌和神经疾病患者的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508112134369740e4a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508112134369740e4a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","XERS"],"gpt_icon":0},{"id":"2557157865","title":"Xeris制药盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557157865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557157865?lang=zh_cn&edition=full","pubTime":"2025-08-08 22:21","pubTimestamp":1754662862,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日22时21分，Xeris制药股票出现异动，股价大幅上涨5.00%。截至发稿，该股报6.93美元/股，成交量100.745万股，换手率0.63%，振幅5.91%。机构评级方面，在所有5家参与评级的机构中，80%的券商给予买入建议，20%的券商给予持有建议，无券商给予卖出建议。Xeris制药股票所在的生物技术行业中，整体跌幅为0.53%。Xeris制药公司简介：Xeris Biopharma Holdings Inc 是一家美国生物制药公司，专注于开发和商业化慢性内分泌和神经疾病患者的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808222102a47d6edd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808222102a47d6edd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XERS","BK4007"],"gpt_icon":0},{"id":"2557569158","title":"Xeris制药股价上涨12.48% 市值涨1.23亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557569158","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557569158?lang=zh_cn&edition=full","pubTime":"2025-08-07 21:31","pubTimestamp":1754573486,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日21时31分，Xeris制药股票出现异动，股价快速上涨12.48%。截至发稿，该股报6.18美元/股，成交量100.712万股，换手率0.63%，振幅12.75%。Xeris制药股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Palisade Bio, Inc.、Niagen Bioscience, Inc.、Sarepta Therapeutics, Inc.涨幅较大，Palisade Bio, Inc.、Processa Pharmaceuticals, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为352.43%、61.97%、20.65%，振幅较大的相关个股有Palisade Bio, Inc.、Xeris制药、Q32 Bio Inc.，振幅分别为14.00%、12.75%、9.21%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807213126a6d8f962&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807213126a6d8f962&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","XERS"],"gpt_icon":0},{"id":"2556434038","title":"Xeris制药盘中异动 下午盘大幅上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556434038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556434038?lang=zh_cn&edition=full","pubTime":"2025-08-02 03:09","pubTimestamp":1754075366,"startTime":"0","endTime":"0","summary":"北京时间2025年08月02日03时09分，Xeris制药股票出现异动，股价快速上涨5.01%。截至发稿，该股报5.35美元/股，成交量172.453万股，换手率1.08%，振幅9.53%。机构评级方面，在所有5家参与评级的机构中，80%的券商给予买入建议，20%的券商给予持有建议，无券商给予卖出建议。Xeris制药股票所在的生物技术行业中，整体涨幅为0.48%。Xeris制药公司简介：Xeris Biopharma Holdings Inc 是一家美国生物制药公司，专注于开发和商业化慢性内分泌和神经疾病患者的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802030927a4703aed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802030927a4703aed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XERS","BK4007"],"gpt_icon":0},{"id":"2555025653","title":"Xeris制药盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555025653","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555025653?lang=zh_cn&edition=full","pubTime":"2025-07-31 00:31","pubTimestamp":1753893068,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日00时31分，Xeris制药股票出现异动，股价急速上涨5.00%。截至发稿，该股报5.25美元/股，成交量56.5377万股，换手率0.35%，振幅4.40%。机构评级方面，在所有5家参与评级的机构中，80%的券商给予买入建议，20%的券商给予持有建议，无券商给予卖出建议。Xeris制药股票所在的生物技术行业中，整体涨幅为0.70%。Xeris制药公司简介：Xeris Biopharma Holdings Inc 是一家美国生物制药公司，专注于开发和商业化慢性内分泌和神经疾病患者的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731003109a6ca07c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731003109a6ca07c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","XERS"],"gpt_icon":0},{"id":"2551138376","title":"Xeris制药盘中异动 股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551138376","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551138376?lang=zh_cn&edition=full","pubTime":"2025-07-15 00:58","pubTimestamp":1752512327,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日00时58分，Xeris制药股票出现波动，股价快速上涨5.09%。截至发稿，该股报5.37美元/股，成交量110.447万股，换手率0.69%，振幅7.44%。Xeris制药股票所在的生物技术行业中，整体涨幅为0.72%。Xeris制药公司简介：Xeris Biopharma Holdings Inc 是一家美国生物制药公司，专注于开发和商业化慢性内分泌和神经疾病患者的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715005848a6a93c58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715005848a6a93c58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","XERS"],"gpt_icon":0},{"id":"2550653247","title":"Xeris制药盘中异动 早盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550653247","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550653247?lang=zh_cn&edition=full","pubTime":"2025-07-09 21:49","pubTimestamp":1752068943,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日21时49分，Xeris制药股票出现波动，股价快速上涨5.03%。截至发稿，该股报5.01美元/股，成交量34.6262万股，换手率0.22%，振幅3.77%。Xeris制药股票所在的生物技术行业中，整体涨幅为0.97%。Xeris制药公司简介：Xeris Biopharma Holdings Inc 是一家美国生物制药公司，专注于开发和商业化慢性内分泌和神经疾病患者的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709214903979fb9bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709214903979fb9bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XERS","BK4007"],"gpt_icon":0},{"id":"2517437677","title":"Piper Sandler：重申Xeris Biopharma Holdings(XERS.US)评级，由中性调整至中性评级, 目标价由3.00美元调整至4.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517437677","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517437677?lang=zh_cn&edition=full","pubTime":"2025-03-07 23:57","pubTimestamp":1741363032,"startTime":"0","endTime":"0","summary":"Piper Sandler：重申Xeris Biopharma Holdings(XERS.US)评级，由中性调整至中性评级, 目标价由3.00美元调整至4.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/07235748604575.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["XERS"],"gpt_icon":0},{"id":"1140090932","title":"异动解读 | Xeris制药财报亮眼 盘中股价大涨9.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=1140090932","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140090932?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:35","pubTimestamp":1741271712,"startTime":"0","endTime":"0","summary":"Xeris制药公司今日盘中股价大涨9.81%,主要得益于公司公布的2024年第四季度财报表现出色。\n根据公司最新的季度财报,Xeris制药实现营收6010万美元,同比大增35.39%,超出分析师预期的5810万美元。此外,公司本季度每股亏损0.03美元,较去年同期的0.10美元减少了70%,也优于分析师预期的0.06美元亏损。\n良好的财报业绩显示,公司业务发展势头强劲、盈利能力持续改善,已步入健康发展轨道。这令投资者对公司未来前景更加看好,从而推高了公司股价在今日盘中的大涨表现。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["XERS"],"gpt_icon":0},{"id":"1102660800","title":"异动解读 | Xeris制药业绩优异 盘前大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=1102660800","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102660800?lang=zh_cn&edition=full","pubTime":"2025-03-06 21:02","pubTimestamp":1741266152,"startTime":"0","endTime":"0","summary":"Xeris制药(XERS)今日盘前大涨5.16%,引发市场关注。具体来看:\n\n公司发布了2024年第四季度财报,亏损和营收均优于市场预期。据财报显示,Xeris制药本季度每股亏损0.03美元,远低于此前分析师预期的0.06美元亏损。与去年同期的0.10美元亏损相比,公司本季度亏损减少了70%。\n营收方面,公司本季度实现销售额6010万美元,同比增长35.39%,超出分析师预期的5810万美元。公司业绩的持续改善,令投资者对未来发展前景更添信心,从而推动股价在今日盘前大涨5.16%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["XERS"],"gpt_icon":0},{"id":"1198272416","title":"Xeris Biopharma Holdings 2024年第四季度GAAP每股亏损$0.03优于预期$0.06，销售额$60.10M优于预期$58.10M","url":"https://stock-news.laohu8.com/highlight/detail?id=1198272416","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198272416?lang=zh_cn&edition=full","pubTime":"2025-03-06 20:02","pubTimestamp":1741262549,"startTime":"0","endTime":"0","summary":"Xeris Biopharma Holdings报告季度每股亏损$0.03，优于分析师预期的$0.06，增幅为50%。相比去年同期每股亏损$0.10，本季度亏损减少了70%。以上内容来自Benzinga Earnings专栏，原文如下：Xeris Biopharma Holdings  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 50 percent. This is a 70 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $60.10 million which beat the analyst consensus estimate of $58.10 million by 3.43 percent.  This is a 35.39 percent increa","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Xeris Biopharma Holdings 2024年第四季度GAAP每股亏损$0.03优于预期$0.06，销售额$60.10M优于预期$58.10M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XERS"],"gpt_icon":0},{"id":"2512690321","title":"Xeris制药盘中异动 股价大涨5.15%报3.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512690321","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512690321?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:09","pubTimestamp":1739891348,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时09分，Xeris制药股票出现异动，股价大幅拉升5.15%。截至发稿，该股报3.78美元/股，成交量65.432万股，换手率0.44%，振幅5.85%。最近的财报数据显示，该股实现营业收入54.27百万美元，净利润-15.74百万美元，每股收益-0.11美元，毛利37.96百万美元，市盈率-8.76倍。Xeris制药股票所在的生物技术行业中，整体涨幅为0.69%。Xeris制药公司简介：Xeris Biopharma Holdings Inc 是一家生物制药公司，为内分泌学，神经病学和胃肠病学的患者群体开发和商业化独特的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218230908988a04b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218230908988a04b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","XERS"],"gpt_icon":0},{"id":"2508999208","title":"Xeris制药盘中异动 下午盘股价大跌5.05%报3.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508999208","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508999208?lang=zh_cn&edition=full","pubTime":"2025-02-01 03:16","pubTimestamp":1738351002,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日03时16分，Xeris制药股票出现波动，股价急速下跌5.05%。截至发稿，该股报3.48美元/股，成交量108.179万股，换手率0.73%，振幅6.28%。Xeris制药股票所在的生物技术行业中，整体涨幅为0.59%。Xeris制药公司简介：Xeris Biopharma Holdings Inc 是一家生物制药公司，为内分泌学，神经病学和胃肠病学的患者群体开发和商业化独特的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020103164298777fb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020103164298777fb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XERS","BK4007"],"gpt_icon":0},{"id":"2505044432","title":"Xeris制药盘中异动 股价大涨5.00%报3.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505044432","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505044432?lang=zh_cn&edition=full","pubTime":"2025-01-22 01:43","pubTimestamp":1737481404,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日01时43分，Xeris制药股票出现波动，股价大幅拉升5.00%。截至发稿，该股报3.36美元/股，成交量74.7161万股，换手率0.50%，振幅4.37%。Xeris制药股票所在的生物技术行业中，整体涨幅为2.04%。Xeris制药公司简介：Xeris Biopharma Holdings Inc 是一家生物制药公司，为内分泌学，神经病学和胃肠病学的患者群体开发和商业化独特的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122014324abb36fc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122014324abb36fc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","XERS"],"gpt_icon":0},{"id":"2503588259","title":"Xeris制药盘中异动 早盘股价大跌6.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503588259","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503588259?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:31","pubTimestamp":1736778708,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时31分，Xeris制药股票出现异动，股价快速下跌6.76%。截至发稿，该股报3.17美元/股，成交量2.0161万股，换手率0.01%，振幅0.59%。Xeris制药股票所在的生物技术行业中，整体跌幅为1.01%。Xeris制药公司简介：Xeris Biopharma Holdings Inc 是一家生物制药公司，为内分泌学，神经病学和胃肠病学的患者群体开发和商业化独特的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132231489864d5b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132231489864d5b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XERS","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xerispharma.com","stockEarnings":[{"period":"1week","weight":0.0041},{"period":"1month","weight":0.0265},{"period":"3month","weight":-0.099},{"period":"6month","weight":0.5681},{"period":"1year","weight":1.1057},{"period":"ytd","weight":1.174}],"compareEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":0.0156},{"period":"3month","weight":0.043},{"period":"6month","weight":0.1226},{"period":"1year","weight":0.148},{"period":"ytd","weight":0.1778}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Xeris Biopharma Holdings, Inc.于2005年根据特拉华州的法律成立。该公司致力于打造一家创新的、自我维持的、以增长为导向的生物制药公司，致力于通过开发一系列疗法中具有临床意义的产品并将其商业化来改善患者的生活。该公司具有独特的优势，通过三种商业产品和专有配方科学（XeriSol和XeriJect）来实现这一目标，从而建立合作伙伴关系并增强候选产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.071149},{"month":2,"riseRate":0.714286,"avgChangeRate":-0.011486},{"month":3,"riseRate":0.571429,"avgChangeRate":-0.030403},{"month":4,"riseRate":0.428571,"avgChangeRate":0.030526},{"month":5,"riseRate":0.714286,"avgChangeRate":0.17169},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.067395},{"month":7,"riseRate":0.5,"avgChangeRate":-0.009808},{"month":8,"riseRate":0.625,"avgChangeRate":0.207997},{"month":9,"riseRate":0.375,"avgChangeRate":-0.064053},{"month":10,"riseRate":0.5,"avgChangeRate":-0.004147},{"month":11,"riseRate":0.5,"avgChangeRate":-0.025098},{"month":12,"riseRate":0.625,"avgChangeRate":0.043356}],"exchange":"NASDAQ","name":"Xeris制药","nameEN":"Xeris Pharmaceuticals Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Xeris制药(XERS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Xeris制药(XERS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Xeris制药,XERS,Xeris制药股票,Xeris制药股票老虎,Xeris制药股票老虎国际,Xeris制药行情,Xeris制药股票行情,Xeris制药股价,Xeris制药股市,Xeris制药股票价格,Xeris制药股票交易,Xeris制药股票购买,Xeris制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Xeris制药(XERS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Xeris制药(XERS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}